Company news: Pfizer, Medialets

Share this article:
Pfizer is laying off workers at two plants in Ireland, reported the Irish Examiner. The paper said the Pfizer layoffs will target about 180 staffers at its Little Island and Ringaskiddy sites, which currently have 220 and 500 workers, respectively. Little Island produces the cholesterol-lowering drug Lipitor, which has seen sales plummet since going off patent last year. Asked if any plants are due to be closed, the drugmaker told MM&M, “Pfizer can confirm that colleague meetings will take place tomorrow morning at Little Island and Ringaskiddy. A statement will be issued following the conclusion of the meetings.”

Advertisers are giving mobile more than a second look. A report by ad platform developer Medialets shows that 40% of its first-quarter clients deployed ads that ran across multiple platforms at once, including handsets, tablets, mobile web and mobile apps. This is double the same percentage clients used in the first quarter of 2011. Medialets also outlined a few mobile sweet spots, including the following: mobile rich-media ads have an enagement rate that is 35% higher than those without video. Plus, consumers spend around 20 seconds with mobile rich-media ads, which can jump to over a minute if they include a game.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.